These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
89 related items for PubMed ID: 21877897
1. NMR spectroscopy for discovery and quantitation of biomarkers of disease in human bile. Gowda GA. Bioanalysis; 2011 Aug; 3(16):1877-90. PubMed ID: 21877897 [Abstract] [Full Text] [Related]
2. Human bile as a rich source of biomarkers for hepatopancreatobiliary cancers. Gowda GA. Biomark Med; 2010 Apr; 4(2):299-314. PubMed ID: 20406071 [Abstract] [Full Text] [Related]
3. Liquid chromatography/nuclear magnetic resonance spectroscopy and liquid chromatography/mass spectrometry identification of novel metabolites of the multidrug resistance modulator LY335979 in rat bile and human liver microsomal incubations. Ehlhardt WJ, Woodland JM, Baughman TM, Vandenbranden M, Wrighton SA, Kroin JS, Norman BH, Maple SR. Drug Metab Dispos; 1998 Jan; 26(1):42-51. PubMed ID: 9443851 [Abstract] [Full Text] [Related]
4. Identification of metabolites in human hepatic bile using 800 MHz 1H NMR spectroscopy, HPLC-NMR/MS and UPLC-MS. Duarte IF, Legido-Quigley C, Parker DA, Swann JR, Spraul M, Braumann U, Gil AM, Holmes E, Nicholson JK, Murphy GM, Vilca-Melendez H, Heaton N, Lindon JC. Mol Biosyst; 2009 Feb; 5(2):180-90. PubMed ID: 19156264 [Abstract] [Full Text] [Related]
5. [Bile electrolytes in patients with chronic diseases of the liver and bile ducts]. Revutskiĭ BI, Shmakov VN, Nechaev EN. Vrach Delo; 1969 Oct; 10():118-20. PubMed ID: 5366772 [No Abstract] [Full Text] [Related]
6. Metabolic profile of chronic liver disease by NMR spectroscopy of human biopsies. Martínez-Granados B, Morales JM, Rodrigo JM, Del Olmo J, Serra MA, Ferrández A, Celda B, Monleón D. Int J Mol Med; 2011 Jan; 27(1):111-7. PubMed ID: 21072494 [Abstract] [Full Text] [Related]
7. In vivo and in vitro nuclear magnetic resonance spectroscopy as a tool for investigating hepatobiliary disease: a review of H and P MRS applications. Khan SA, Cox IJ, Hamilton G, Thomas HC, Taylor-Robinson SD. Liver Int; 2005 Apr; 25(2):273-81. PubMed ID: 15780050 [Abstract] [Full Text] [Related]
8. [Disruption of the electrolyte and microelement composition of gastric juice and bile in patients with chronic diseases of the hepatobiliary system]. Gubergrits AIa, Revutskiĭ BI, Shmakov VN. Vrach Delo; 1989 May; (5):64-6. PubMed ID: 2773439 [Abstract] [Full Text] [Related]
9. [Clinical importance of studying the free biliary acids of the bile in certain diseases of the hepatobiliary system]. Abramzon MA, Popova RA, Ripatti PO. Vrach Delo; 1975 Mar; (3):72-4. PubMed ID: 1121842 [No Abstract] [Full Text] [Related]
11. Sulfated and nonsulfated bile acids in urine, serum, and bile of patients with hepatobiliary diseases. Makino I, Hashimoto H, Shinozaki K, Yoshino K, Nakagawa S. Gastroenterology; 1975 Mar; 68(3):545-53. PubMed ID: 1112456 [Abstract] [Full Text] [Related]
12. Potential of human saliva for nuclear magnetic resonance-based metabolomics and for health-related biomarker identification. Bertram HC, Eggers N, Eller N. Anal Chem; 2009 Nov 01; 81(21):9188-93. PubMed ID: 19780580 [Abstract] [Full Text] [Related]
13. Metabolomics tools for identifying biomarkers for neuropsychiatric diseases. Quinones MP, Kaddurah-Daouk R. Neurobiol Dis; 2009 Aug 01; 35(2):165-76. PubMed ID: 19303440 [Abstract] [Full Text] [Related]
14. Understanding subfertility at a molecular level in the female through the application of nuclear magnetic resonance (NMR) spectroscopy. Baskind NE, McRae C, Sharma V, Fisher J. Hum Reprod Update; 2011 Aug 01; 17(2):228-41. PubMed ID: 20801939 [Abstract] [Full Text] [Related]
15. Identification of urinary biomarkers useful for distinguishing a difference in mechanism of toxicity in rat model of cholestasis. Ishihara K, Katsutani N, Asai N, Inomata A, Uemura Y, Suganuma A, Sawada K, Yokoi T, Aoki T. Basic Clin Pharmacol Toxicol; 2009 Sep 01; 105(3):156-66. PubMed ID: 19486331 [Abstract] [Full Text] [Related]
16. Proteomic analysis of human bile and potential applications for cancer diagnosis. Farina A, Dumonceau JM, Lescuyer P. Expert Rev Proteomics; 2009 Jun 01; 6(3):285-301. PubMed ID: 19489700 [Abstract] [Full Text] [Related]
17. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126. Lenz EM, D'Souza RA, Jordan AC, King CD, Smith SM, Phillips PJ, McCormick AD, Roberts DW. J Pharm Biomed Anal; 2007 Feb 19; 43(3):1065-77. PubMed ID: 17030109 [Abstract] [Full Text] [Related]
18. Metabonomics investigation of human urine after ingestion of green tea with gas chromatography/mass spectrometry, liquid chromatography/mass spectrometry and (1)H NMR spectroscopy. Law WS, Huang PY, Ong ES, Ong CN, Li SF, Pasikanti KK, Chan EC. Rapid Commun Mass Spectrom; 2008 Aug 19; 22(16):2436-46. PubMed ID: 18634125 [Abstract] [Full Text] [Related]
19. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS). Chan EC, Koh PK, Mal M, Cheah PY, Eu KW, Backshall A, Cavill R, Nicholson JK, Keun HC. J Proteome Res; 2009 Jan 19; 8(1):352-61. PubMed ID: 19063642 [Abstract] [Full Text] [Related]
20. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Beckonert O, Keun HC, Ebbels TM, Bundy J, Holmes E, Lindon JC, Nicholson JK. Nat Protoc; 2007 Jan 19; 2(11):2692-703. PubMed ID: 18007604 [Abstract] [Full Text] [Related] Page: [Next] [New Search]